Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37459705)
Watch
English
Bevacizumab for recurrent ependymoma.
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
title
Bevacizumab for recurrent ependymoma
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
main subject
bevacizumab
1 reference
based on heuristic
inferred from title
author
Lisa M DeAngelis
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
Timothy F. Cloughesy
series ordinal
2
object named as
T F Cloughesy
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
author name string
R M Green
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
R Stupp
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
E A Woyshner
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
D E Ney
series ordinal
6
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
A B Lassman
series ordinal
7
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
language of work or name
English
0 references
publication date
1 November 2009
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
published in
Neurology
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
volume
73
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
issue
20
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
page(s)
1677-1680
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
cites work
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788805
retrieved
23 August 2017
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788805
retrieved
23 August 2017
Cytokine and growth factor responses after radiotherapy for localized ependymoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788805
retrieved
23 August 2017
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788805
retrieved
23 August 2017
A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788805
retrieved
23 August 2017
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788805
retrieved
23 August 2017
Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788805
retrieved
2 September 2018
Response criteria for phase II studies of supratentorial malignant glioma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788805
retrieved
2 September 2018
Identifiers
DOI
10.1212/WNL.0B013E3181C1DF34
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
PMC publication ID
2788805
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
PubMed publication ID
19917990
1 reference
stated in
Europe PubMed Central
PMC publication ID
2788805
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19917990%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit